References
- Gawkrodger D J. On behalf of the Therapy Guidelines and Audit Subcommittee of the British Association of Dermatologists, Current management of psoriasis. J Dermatol Treat 1997; 8: 27–55
- Tuyp E, Mackie R M. Combination therapy for psoriasis with methotrexate and etretinate. J Am Acad Dermatol 1986; 14: 70–3
- Rosenbaum M M, Roenigk H H. Treatment of generalized pustular psoriasis with etretinate and methotrexate. J Am Acad Dermatol 1984; 10: 357–61
- Vanderveen E E, Ellis C N, Campbell J P, et al. Methotrexate and etretinate as concurrent therapies in severe psoriasis. Arch Dermatol 1982; 118: 660–2
- Korstanje M J, van Breda Vriesman C JP, van de Staak W JBM. Cyclosporin and methotrexate: a dangerous combination. J Am Acad Dermatol 1990; 23: 321
- Brechtel Wellenreuther B. U, Toppe E, et al. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis. J Am Acad Dermatol 1994; 30: 1023–4
- Beck H, Foged E K. Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis. Dermatologica 1983; 167: 94–6
- Zachariae H. Dangers of methotrexateetretinate combination therapy. Lancet 1988; 1: 422, (letter)